Medicamen Organics Share Price

Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited, as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana. Subsequently, the name of Company changed to Medicamen Organics Limited and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi.Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer. The product portfolio consists of 84 products and comprises of wide range of drugs like, AntiBacterial, Anti Diarrheal, AntiFungal, AntiMalarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, AntiHypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal antiinflammatory drug (NSAIDS). It has two manufacturing units in Haridwar. Further, Company is strategically focusing on establishing a direct presence in international market for an instance in 2023, it directly exported the product in Burundi. These products are marketed across India as well as African, Commonwealth of Independent States (CIS) region and South East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by thirdparty distributor.In 1996, the Company started with trading of pharmaceuticals for supplies to various Government departments. During the period 2007, it started construction for own pharma unit at Ranipur, in Haridwar and received WHO/GMP Certificate for Unit I. In 2010, it got license for manufacturing of food supplements, like protein powders, vitamin tablets and syrups etc. In 2017, it formed a joint venture with Denish Company and gave them authority for worldwide export of Iron Products. The joint venture company, in turn, got 50% equity in the Company.Company issued 31,00,000 equity shares of Rs 10 each and raised a fresh issue aggregating to Rs 10.54 crores through a public issue on June 25, 2024. In 2025, Company incorporated Grand Etoile Pharmaceuticals Ltd as newly subsidiary focused on branding of pharmaceuticals in Africa and Cosmetics Brand LOIRE globally.